Cargando…
Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy
Chronic Kidney Disease is a growing problem across the world and can lead to end-stage kidney disease and cardiovascular disease. Fibrosis is the underlying mechanism that leads to organ dysfunction, but as yet we have no therapeutics that can influence this process. Ras monomeric GTPases are master...
Autores principales: | Newbury, Lucy J., Wang, Jui-Hui, Hung, Gene, Hendry, Bruce M., Sharpe, Claire C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768870/ https://www.ncbi.nlm.nih.gov/pubmed/31570767 http://dx.doi.org/10.1038/s41598-019-50422-7 |
Ejemplares similares
-
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001) -
Kirsten Ras* oncogene: Significance of its discovery in human cancer research
por: Tsuchida, Nobuo, et al.
Publicado: (2016) -
The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription
por: Cogoi, Susanna, et al.
Publicado: (2018) -
Role of Poly [ADP-ribose] Polymerase 1 in Activating the Kirsten
ras (KRAS) Gene in Response to Oxidative Stress
por: Cinque, Giorgio, et al.
Publicado: (2020) -
Calreticulin is important for the development of renal fibrosis and dysfunction in diabetic nephropathy
por: Lu, Ailing, et al.
Publicado: (2020)